Annual Lung SPORE Workshop (Abstract Submission)

Filter submissions
76 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Fri, 03/08/2024 - 18:05 Monique (Presented by Heymach) Nilsson mnilsson@mdanderson.org 7137458407 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Trastuzumab deruxtecan resistance can be mediated by payload resistance or secondary extracellular ERBB2 mutations but sensitivity to HER2 tyrosine kinase inhibitors is maintained John Heymach (Submitted by M. Nilsson) MD Anderson Cancer Center
  • First Name: Xiuning
    Last Name: Le
    Affiliation: MDACC
  • First Name: Junqin
    Last Name: He
    Affiliation: MDACC
  • First Name: Xiaoxing
    Last Name: Yu
    Affiliation: MDACC
  • First Name: Xiaofang
    Last Name: Huo
    Affiliation: UTSW
  • First Name: Ashwani
    Last Name: Kumar
    Affiliation: UTSW
  • First Name: Alissa
    Last Name: Poteete
    Affiliation: MDACC
  • First Name: Qian
    Last Name: Huang
    Affiliation: MDACC
  • First Name: Ralf
    Last Name: Kittler
    Affiliation: UTSW
  • First Name: John
    Last Name: Heymach
    Affiliation: MDACC
 Abstract_Submission.pdf No
Mon, 05/13/2024 - 12:50 Robert Hsu robert.hsu@med.usc.edu 9148153821 Session 2: Health Disparities in Lung Cancer Real-World Molecular Testing Disparities at a Large Academic Institution in Los Angeles

Robert Hsu University of Southern California Norris Comprehensive Cancer Center
  • First Name: Darin
    Last Name: Poei
    Affiliation: University of Southern California
  • First Name: Jacob
    Last Name: Thomas
    Affiliation: University of Southern California Norris Comprehensive Cancer Center
  • First Name: Jorge
    Last Name: Nieva
    Affiliation: University of Southern California Norris Comprehensive Cancer Center
 Abstract_Submission.pdf No
Tue, 02/20/2024 - 09:01 May-Lucie Meyer may-lucie.meyer@mssm.edu Session 4: Small Cell Lung Cancer, Session 6: Cancer Biology DLL3 expression in early-stage SCLC: comparative analysis of IHC and mRNA ISH May-Lucie Meyer Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA
  • First Name: Hui
    Last Name: Yu
    Affiliation: Medical Oncology, University ofColorado Anschutz Campus, Aurora, USA
  • First Name: Zoltan
    Last Name: Lohinai
    Affiliation: OKTPI-Koranyi National Institute, Budapest, Hungary
  • First Name: Grace
    Last Name: van Hyfte
    Affiliation: epartment of Population HealthScience and Policy, Icahn School of Medicine at Mount Sinai, New York, USA
  • First Name: Fred
    Last Name: Hirsch
    Affiliation: Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA
 Abstract_Submission.pdf No Approved to be a Poster Presenter DLL3 expression in SCLC Poster.jpeg
Thu, 02/29/2024 - 15:57 Bluma Lesch bluma.lesch@yale.edu 203-737-1074 Session 6: Cancer Biology Mechanisms of epigenetic sensitization to lung cancer risk Benjamin Walters Yale University
  • First Name: Jianlei
    Last Name: Gu
    Affiliation: Yale University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Wed, 03/06/2024 - 18:26 David MacPherson dmacpher@fredhutch.org 2066676464 Session 4: Small Cell Lung Cancer In vivo functional screens identify drivers of chemoresistance in small cell lung cancer Scott Best Fred Hutch
  • First Name: Lauren
    Last Name: Brumage
    Affiliation: Fred Hutch
  • First Name: Daniel
    Last Name: Hippe
    Affiliation: Fred Hutch
  • First Name: Eli
    Last Name: Grunblatt
    Affiliation: Fred Hutch
  • First Name: Pritha
    Last Name: Chanana
    Affiliation: Fred Hutch
  • First Name: Feinan
    Last Name: Wu
    Affiliation: Fred Hutch
  • First Name: Richard
    Last Name: Ivey
    Affiliation: Fred Hutch
  • First Name: Jacob
    Last Name: Kennedy
    Affiliation: Fred Hutch
  • First Name: Myung Chang
    Last Name: Lee
    Affiliation: Genentech
  • First Name: Zhe
    Last Name: Ying
    Affiliation: Fred Hutch
  • First Name: Ali
    Last Name: Ibrahim
    Affiliation: Fred Hutch
  • First Name: Jae Heun
    Last Name: Chung
    Affiliation: Fred Hutch
  • First Name: Anna
    Last Name: Vigil
    Affiliation: Fred Hutch
  • First Name: Jackson
    Last Name: Fatherree
    Affiliation: Fred Hutch
  • First Name: Slobodan
    Last Name: Beronja
    Affiliation: Fred Hutch
  • First Name: Patrick
    Last Name: Paddison
    Affiliation: Fred Hutch
  • First Name: Lucas
    Last Name: Sullivan
    Affiliation: Fred Hutch
  • First Name: Amanda
    Last Name: Paulovich
    Affiliation: Fred Hutch
  • First Name: Barzin
    Last Name: Nabet
    Affiliation: Genentech
  • First Name: David
    Last Name: MacPherson
    Affiliation: Fred Hutch
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Fri, 03/08/2024 - 13:42 Shi-Yong Sun ssun@emory.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Inhibition of hTERT/telomerase/telomere as an important mechanism mediating therapeutic efficacy of third generation EGFR inhibitors in EGFR mutant lung cancer Zhen Chen Emory University
  • First Name: Karin
    Last Name: Vallega
    Affiliation: Emory University
  • First Name: Dongsheng
    Last Name: Wang
    Affiliation: Emory University
  • First Name: Zhihan
    Last Name: Quan
    Affiliation: Xiangya Second Hospital
  • First Name: Songqing
    Last Name: Fan
    Affiliation: Xiangya Second Hospital
  • First Name: Qiming
    Last Name: Wang
    Affiliation: Henan Cancer Hospital
  • First Name: Ticiana
    Last Name: Leal
    Affiliation: Emory University
  • First Name: Ramalingam
    Last Name: Suresh
    Affiliation: Emory University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Fri, 03/08/2024 - 19:37 Boning Gao boning.gao@utsouthwestern.edu 2146484915 Session 6: Cancer Biology New human cell line models for the study of pathogenesis of SARS-CoV-2 infection Boning Gao UT Southwestern
  • First Name: Ian
    Last Name: Boys
    Affiliation: UT Southwestern
  • First Name: Sara
    Last Name: El Zahed
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: Kimberley
    Last Name: Avila
    Affiliation: UT Southwestern
  • First Name: Long Shan
    Last Name: Li
    Affiliation: UT Southwestern
  • First Name: Luc
    Last Name: Girard
    Affiliation: UT Southwestern
  • First Name: Hyunsil
    Last Name: Park
    Affiliation: UT Southwestern
  • First Name: Victor
    Last Name: Stastny
    Affiliation: UT Southwestern
  • First Name: Kenneth
    Last Name: Huffman
    Affiliation: UT Southwestern
  • First Name: Shreoshi Pal
    Last Name: Choudhuri
    Affiliation: UT Southwestern
  • First Name: Kimberly
    Last Name: Batten
    Affiliation: UT Southwestern
  • First Name: Matthew
    Last Name: Esparza
    Affiliation: UT Southwestern
  • First Name: Benjamin
    Last Name: Drapkin
    Affiliation: UT Southwestern
  • First Name: Lisa
    Last Name: Miorin
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: Jerry
    Last Name: Shay
    Affiliation: UT Southwestern
  • First Name: Wendy
    Last Name: Maury
    Affiliation: University of Iowa
  • First Name: Beatriz
    Last Name: Fontoura
    Affiliation: UT Southwestern
  • First Name: John
    Last Name: Schoggins
    Affiliation: UT Southwestern
  • First Name: Adolfo
    Last Name: Garcia-Sastre
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: John
    Last Name: Minna
    Affiliation: UT Southwestern
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Fri, 03/08/2024 - 21:20 Michael Oh michaeloh@mednet.ucla.edu 7169829966 Session 3: Immuno-oncology Phase I trial of intratumoral administration of autologous CCL21 gene-modified dendritic cells combined with pembrolizumab reveals local and systemic immune activation in advanced NSCLC Bin Liu UCLA
  • First Name: Aaron
    Last Name: Lisberg
    Affiliation: UCLA
  • First Name: Michael
    Last Name: Oh
    Affiliation: UCLA
  • First Name: Ramin
    Last Name: Salehi-Rad
    Affiliation: UCLA and VA Greater Los Angeles Health Care Center
  • First Name: Linh
    Last Name: Tran
    Affiliation: UCLA and VA Greater Los Angeles Health Care Center
  • First Name: Raymond
    Last Name: Lim
    Affiliation: UCLA
  • First Name: Camelia
    Last Name: Dumitras
    Affiliation: UCLA
  • First Name: Zhe
    Last Name: Jing
    Affiliation: UCLA
  • First Name: Fereidoun
    Last Name: Abtin
    Affiliation: UCLA
  • First Name: Robert
    Last Name: Suh
    Affiliation: UCLA
  • First Name: Scott
    Last Name: Genshaft
    Affiliation: UCLA
  • First Name: Scott
    Last Name: Oh
    Affiliation: UCLA
  • First Name: Gregory
    Last Name: Fishbein
    Affiliation: UCLA
  • First Name: Anita
    Last Name: Kaul
    Affiliation: UCLA
  • First Name: Kanwarpal
    Last Name: Kahlon
    Affiliation: UCLA
  • First Name: Shahryar
    Last Name: Ashouri
    Affiliation: UCLA
  • First Name: Jay
    Last Name: Lee
    Affiliation: UCLA
  • First Name: Kostyantyn
    Last Name: Krysan
    Affiliation: UCLA and VA Greater Los Angeles Health Care Center
  • First Name: Jonathan
    Last Name: Goldman
    Affiliation: UCLA
  • First Name: David
    Last Name: Elashoff
    Affiliation: UCLA
  • First Name: Edward
    Last Name: Garon
    Affiliation: UCLA
  • First Name: Steven
    Last Name: Dubinett
    Affiliation: UCLA and VA Greater Los Angeles Health Care Center
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sat, 03/09/2024 - 12:58 Yuji Shibata yshibata@mdanderson.org 3462274948 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Pan-HER inhibition overcomes feedback adaptation resistance to KRAS G12C inhibition in KRAS G12C mutant non-small cell lung cancer Yuji Shibata Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Hibiki
    Last Name: Udagawa
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Monique
    Last Name: Nilsson
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Jacqulyne
    Last Name: Robichaux
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Ana
    Last Name: Galan-Cobo
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: David
    Last Name: Molkentine
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Junqin
    Last Name: He
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Qian
    Last Name: Huang
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Marcelo
    Last Name: Negrao
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Xiaoxing
    Last Name: Yu
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Alissa
    Last Name: Poteete
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Qian
    Last Name: Yu
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Ferdinandos
    Last Name: Skoulidis
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: John
    Last Name: Heymach
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 03:47 Catherine Meador cbmeador@mgh.harvard.edu 9192603477 Session 4: Small Cell Lung Cancer Detecting small cell transformation in patients with advanced EGFR mutant lung adenocarcinoma through epigenomic cfDNA profiling Catherine Meador Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Talal
    Last Name: El Zarif
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Xintao
    Last Name: Qiu
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Ji-Heui
    Last Name: Seo
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Matthew
    Last Name: Davidsohn
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Hunter
    Last Name: Savignano
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Gitanjali
    Last Name: Lakshminaranan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Heather
    Last Name: McClure
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: John
    Last Name: Canniff
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Brad
    Last Name: Fortunato
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Rong
    Last Name: Li
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Mandeep
    Last Name: Banwait
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Karl
    Last Name: Semaan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Marc
    Last Name: Eid
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Henry
    Last Name: Long
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Yin
    Last Name: Hung
    Affiliation: Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Navin
    Last Name: Mahadevan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: David
    Last Name: Barbie
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Matthew
    Last Name: Oser
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Zofia
    Last Name: Piotrowska
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Toni
    Last Name: Choueiri
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Sylvan
    Last Name: Baca
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Aaron
    Last Name: Hata
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Matthew
    Last Name: Freedman
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Jacob
    Last Name: Berchuck
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 12:47 Jessie Hao jessie.hao@emory.edu 4705423594 Session 6: Cancer Biology Co-occurring genomic alterations-guided in silico discovery of therapeutic vulnerability in lung adenocarcinoma Jessie Hao Department of Pharmacology and Chemical Biology, Emory University School of Medicine
  • First Name: Xiulei
    Last Name: Mo
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 14:15 Triparna Sen triparna.sen@gmail.com 9179723836 Session 4: Small Cell Lung Cancer Transcriptional and epigenetic landscape of neuroendocrine transformation during emergence of resistance to targeted therapies in EGFR mutant lung adenocarcinoma. Triparna Sen Icahn School of Medicine at Mount Sinai Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 16:59 Triparna Sen triparna.sen@mssm.edu 9179723836 Session 3: Immuno-oncology ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes anti-tumor immunity in SCLC. Triparna Sen Icahn School of Medicine at Mount Sinai Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 16:56 Siyuan Wang siyuan.wang@yale.edu 2037854511 Session 6: Cancer Biology A genome-wide single-cell 3D genome atlas of lung cancer progression Miao Liu Yale University Department of Genetics
  • First Name: Shengyan
    Last Name: Jin
    Affiliation: Yale University Department of Genetics
  • First Name: Sherry
    Last Name: Agabiti
    Affiliation: Yale University Department of Genetics
  • First Name: Tyler
    Last Name: Jensen
    Affiliation: Yale University Department of Genetics
  • First Name: Tianqi
    Last Name: Yang
    Affiliation: Yale University Department of Genetics
  • First Name: Jonathan
    Last Name: Radda
    Affiliation: Yale University Department of Genetics
  • First Name: Christian
    Last Name: Ruiz
    Affiliation: Yale University Department of Genetics
  • First Name: Gabriel
    Last Name: Baldissera
    Affiliation: Yale University Department of Genetics
  • First Name: Mandar
    Last Name: Muzumdar
    Affiliation: Yale University Department of Genetics, Department of Internal Medicine, Yale Cancer Biology Institute, Yale Cancer Center
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 17:40 Jia Luo jia_luo@dfci.harvard.edu 6176323000 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Clinicopathologic and genomic features of patients with mucinous lung adenocarcinoma and response to systemic therapies Alessandro Di Federico DFCI
  • First Name: Lingzhi
    Last Name: Hong
    Affiliation: MDACC
  • First Name: Arielle
    Last Name: Elkrief
    Affiliation: MSKCC
  • First Name: Rohit
    Last Name: Thummalapalli
    Affiliation: MSKCC
  • First Name: Biagio
    Last Name: Ricciuti
    Affiliation: DFCI
  • First Name: Joao
    Last Name: Alessi
    Affiliation: DFCI
  • First Name: Pooja
    Last Name: Gogia
    Affiliation: MSKCC
  • First Name: Federica
    Last Name: Pecci
    Affiliation: DFCI
  • First Name: Malini
    Last Name: Gandhi
    Affiliation: DFCI
  • First Name: Marc
    Last Name: Ladanyi
    Affiliation: MSKCC
  • First Name: Jianjun
    Last Name: Zhang
    Affiliation: MDACC
  • First Name: Don
    Last Name: Gibbons
    Affiliation: MDACC
  • First Name: John
    Last Name: Heymach
    Affiliation: MDACC
  • First Name: Mizuki
    Last Name: Nishino
    Affiliation: DFCI
  • First Name: Lynette
    Last Name: Sholl
    Affiliation: BWH
  • First Name: Mark
    Last Name: Awad
    Affiliation: DFCI
  • First Name: Kathryn
    Last Name: Arbour
    Affiliation: MSKCC
  • First Name: Adam
    Last Name: Schoenfeld
    Affiliation: MSKCC
  • First Name: Natalie
    Last Name: Vokes
    Affiliation: MDACC
  • First Name: Jia
    Last Name: Luo
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:03 Caro Kravitz caro.kravitz@yale.edu Session 6: Cancer Biology The lysine demethylase KDM2A regulates tumor cell clustering to potentiate metastasis Caro Kravitz Yale University
  • First Name: Kiran
    Last Name: Patel
    Affiliation: Yale
  • First Name: Wesley
    Last Name: Cai
    Affiliation: Yale
  • First Name: Anna
    Last Name: Arnal-Estapé
    Affiliation: Yale
  • First Name: Dejian
    Last Name: Zhao
    Affiliation: Yale
  • First Name: Emily
    Last Name: Wingrove
    Affiliation: Yale
  • First Name: Laura
    Last Name: Stevens
    Affiliation: Yale
  • First Name: Thomas
    Last Name: Westbrook
    Affiliation: Baylor
  • First Name: Qin
    Last Name: Yan
    Affiliation: Yale
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:25 Diane Yang dyang17@mgh.harvard.edu Session 6: Cancer Biology Profiling the protein interactome through cysteine-reactive libraries has revealed the identification of EML4ALK dimerizers Diane Yang Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Harry
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Elizabeth
    Last Name: Codd
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Kaluziak
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Edwin
    Last Name: Zhang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Alexander Daniel
    Last Name: Carlin
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Zavontae
    Last Name: Oppong-Holmes
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Wendy
    Last Name: Yang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Abigail
    Last Name: Smith
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Dawn
    Last Name: Mitchell
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Mariko
    Last Name: Hara
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Siwen
    Last Name: Zhang
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Harrison Byron
    Last Name: Chong
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Maristela
    Last Name: Onozato
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Liron
    Last Name: Bar-Peled
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: A. John
    Last Name: Iafrate
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:52 Matthew Wang matthew.wang.mcw69@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Understanding the role of alternative RNA splicing in Osimertinib resistance in lung adenocarcinoma Matthew Wang Department of Molecular Biophysics and Biochemistry, Yale University, USA
  • First Name: Robert
    Last Name: Tesng
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Li-Ting
    Last Name: Ku
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Xinning
    Last Name: Shan
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Joanne
    Last Name: Chen
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Department of Pathology, Yale University, USA
  • First Name: Luisa
    Last Name: Escobar-Hoyos
    Affiliation: Department of Molecular Biophysics and Biochemistry, Yale University, USA; Department of Therapeutic Radiology, Yale University, USA
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 21:37 Tang Tang tang.tang@yale.edu 5307509166 Session 3: Immuno-oncology Modeling immune evasion and immunotherapy response in distant metastases of lung adenocarcinoma Tang Tang Yale School of Medicine
  • First Name: Kelli
    Last Name: Conolly
    Affiliation: Yale School of Medicine
  • First Name: Nikhil
    Last Name: Joshi
    Affiliation: Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale School of Medicine
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 23:49 Ling Cai ling.cai.30@gmail.com 2146975362 Session 6: Cancer Biology A Lung Cancer Mouse Model Database Ling Cai Quantitative Biomedical Research Center, School of Public Health, University of Texas Southwestern Medical Center Abstract_Submission.pdf
Cai_UTSW_6.docx15.39 KB
No Approved to be a Poster Presenter